The possible mechanism of GM dysbiosis associated with cardiovascular diseases involves the participation of intestinal microbiota in increasing intestinal permeability and inducing inflammation via the LPS/TLR4 signalling pathways and the NLRP3 pathways, thereby contributing to the development of cardiovascular diseases [193]. Here, TLR4 is linked to cardiovascular disorder.